On the assumption that, like me, you’re either running to get somewhere for Thanksgiving or preparing for the arrival of a bunch of peeps running towards you, I apologize for breaking in with a weedy tax discussion. But break in I must, as while you’re innocently stuffing a bird, candying the yams, and burning the… Read more
Just trying to keep it a bit real, over at PostEverything.
I told the (totally awesome) audience at the Tampa, FL meeting of the Council on Social Work Education that I’d post my presentation ASAP. Here it is. A few clarifications. YOYO=you’re on your own WITT=we’re in this together In case the video doesn’t work, go here and start at 1:40. And h/t to Chuck Sheketoff for… Read more
The big story in tax inversion land is that despite their full-speed-ahead plans of a few weeks ago, the American big-pharma firm AbbVie might not acquire the Irish drug maker Shire. According to the NYT: If the merger were to fall apart, it would be the biggest casualty of new tax rules aimed at inversion… Read more
I favorably reviewed Ed Kleinbard’s book here the other day so I’m obliged to step in and correct what looks to me like a misimpression growing out of an oped he has in today’s NYT. Because the oped is entitled “Don’t Soak the Rich” and because Ed, IMHO, doesn’t articulate the nuances in his argument… Read more